ICE team now has 250+ dy-to-use for panel based viability screening, and we are keep expanding bank dramatically this year where we’ll procure another 500+ wild type re panel based assays will come soon like:
1, notype screening in our automatic screening center with high throughput facilities
2, Find sensitive CDX model
3, Evaluate biomarker expression or regulation across an>
4, Check protein expression and degradation in different types
5, Profile compound cytoarious types of an>
We are hoping to do more exploratory work with you in the near future!
Welcome any further communication or plan on ICE’s panel platform.
Signup today to claim your Discount. Get Started before it's too late!
